Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.22 USD | -0.44% |
|
+1.38% | +14.65% |
15/07 | ANI Pharmaceuticals Launches L-Glutamine Oral Powder Following FDA Approval | MT |
15/07 | ANI Pharmaceuticals, Inc. Announces the FDA Approval and Launch of L-Glutamine Oral Powder | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.65% | 122.7Cr | |
+63.05% | 86TCr | |
+39.42% | 63TCr | |
-4.78% | 36TCr | |
+17.52% | 32TCr | |
+8.43% | 30TCr | |
+14.19% | 24TCr | |
+5.81% | 23TCr | |
+16.77% | 23TCr | |
+14.63% | 18TCr |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- ANI Pharmaceuticals Launches L-Glutamine Oral Powder Following FDA Approval